BIO-TECHNE Corp TECH Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jan 15, 2021 (filed on Jan 20, 2021)

Insider Name:

Kummeth Charles R.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-20,000

Price:

$344.00
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Stock Options (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-10,000

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,009

Price:

$334.98
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-3,990

Price:

$334.39
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,501

Price:

$333.23
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-700

Price:

$331.61
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-400

Price:

$330.27
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-400

Price:

$328.68
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

10,000

Price:

$106.59
Dec 07, 2020 (filed on Dec 09, 2020)

Insider Name:

Kummeth Charles R.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-5,000

Price:

$308.00

Filings by filing date

Jan 15, 2021 (filed on Jan 20, 2021)

Insider Name:

Kummeth Charles R.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-20,000

Price:

$344.00
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Stock Options (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-10,000

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,009

Price:

$334.98
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-3,990

Price:

$334.39
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-2,501

Price:

$333.23
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-700

Price:

$331.61
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-400

Price:

$330.27
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-400

Price:

$328.68
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Hippel James

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

10,000

Price:

$106.59
Dec 07, 2020 (filed on Dec 09, 2020)

Insider Name:

Kummeth Charles R.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-5,000

Price:

$308.00

News

Biz Brief

Sector: Healthcare	Industry: Biotechnology & Medical Research

See Regulatory Filings on SEC

Company Contact

Address:	614 McKinley Pl NE MINNEAPOLIS MN 55413-2610
Tel:	1-646-2771266
Website:	https://www.bio-techne.com
IR:	See website

Key People

Robert V. Baumgartner Independent Chairman of the Board	Charles R. Kummeth President, Chief Executive Officer, Director	James T. Hippel Chief Financial Officer, Executive Vice President - Finance
David Eansor President - Protein Sciences	Kim Kelderman President - Diagnostics and Genomics	Brenda S. Furlow Senior Vice President, General Counsel, Corporate Secretary

Business Overview

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market.

Financial Overview

For the three months ended 30 September 2020,BIO-TECHNE Corp revenues increased 11% to $204.2M. Netincome applicable to common stockholders increased from$14.3M to $33.4M. Revenues reflect Protein Sciences segmentincrease of 10% to $154.4M, Diagnostics and Genomicssegment increase of 18% to $50.1M, United States segmentincrease of 11% to $113.6M, U.K segment increase of 11% to$43.1M, Greater China segment increase of 12% to $18.1M.

Employees:	2,300 as of Jun 30, 2020

Reporting Currency:	U.S. Dollars
Enterprise value:	$13,804M as of Sep 30, 2020
Annual revenue (TTM):	$759.65M as of Sep 30, 2020
EBITDA (TTM):	$256.25M as of Sep 30, 2020
Net annual income (TTM):	$248.14M as of Sep 30, 2020
Free cash flow (TTM):	$129.46M as of Sep 30, 2020
Net Debt Last Fiscal Year:	$36.25M as of Sep 30, 2020
Shares outstanding:	38,609,307 as of Nov 2, 2020
Index Membership:	S&P 400 Mid Cap
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

BIO-TECHNE Corp (OQ:TECH)